FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / indemnification-analysis-memo.docx
indemnification-analysis-memo.docx · 1018-00006

Parties

Harkness LLP
Penterra Pharmaceuticals Corp
Meridian Bio Therapeutics Ltd
Firth LLP
M. Firth
Meridian Korea Inc
Meridian Bio Australia Pty Ltd
Alkerra Manufacturing Inc

Dates

September 20, 2023
September 15, 2023
October 2, 2023
October 20, 2023
October 20, 2025
August 12, 2037
November 3, 2038
December 19, 2023

Amounts

$120,000,000
$18,000,000
$32,000,000
$25,000,000
$45,000,000
$150,000
$750,000
$36,000,000
$50,000
$500,000

Obligations

1 of the License Agreement provides that Penterra shall indemnify, defend, and hold harmless Meridian and its Affiliates — including Meridian Pharma (Shanghai) Co
Each sublicense must contain indemnification terms that are no less protective of Penterra's rights than the corresponding provisions of the License Agreement
An individual claim must first exceed the $150,000 de minimis threshold to qualify as an indemnifiable loss
Upon assuming control of the defense, the Indemnifying Party shall diligently prosecute the defense to a final conclusion or settlement
However, to the extent the Indemnified Party actually receives insurance proceeds with respect to a loss for which indemnification has been paid, the Indemnified Party must promptly reimburse the Indemnifying Party in the amount of such insurance proceeds (net of any costs of recovery), to prevent double recovery
Meridian is required to conduct a quarterly reconciliation of Territory net prices against the applicable U